Innovation1 Biotech

(OTC) IVBT

Current Price$0.00

Market Cap$4,500

Since IPO (2017)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Innovation1 Biotech Financials at a Glance

Market Cap

$4,500

Revenue (TTM)

$104.87K

Net Income (TTM)

$5.30M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

1.00 (Average)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

IVBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Innovation1 Biotech

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Frederick E. Pierce, II

Website

www.innovation1bio.com

Headquarters

Somerville, NY 10005, US

IVBT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

43%

Return on Assets

-79%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.50K

Shares Outstanding

22.47M

Volume

Avg. Volume

17.365

Financials (TTM)

Gross Profit

$52.70K

Operating Income

$1.37M

EBITDA

$5.68M

Operating Cash Flow

$620.20K

Capital Expenditure

$5.00

Free Cash Flow

$620.20K

Cash & ST Invst.

$49.85K

Total Debt

$229.00K

Innovation1 Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$261.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.50K

N/A

Market Cap/Employee

$4.50K

N/A

Employees

N/A

Net Income

$290.00K

+51.9%

EBITDA

$149.74K

+73.5%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Net Cash

$497.54K

-2573.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$555.06K

+2382.2%

Short Term Debt

$50.00K

+400.0%

Return on Assets

-78.80%

N/A

Return on Invested Capital

42.57%

N/A

Free Cash Flow

$148.29K

+29.0%

Operating Cash Flow

$148.29K

+29.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BXRXQBaudax Bio, Inc.

BXRXQBaudax Bio, Inc.$0.00+0.00%

KLDOKaleido Biosciences, Inc.

KLDOKaleido Biosciences, Inc.$0.00+0.00%

XENOXeno Transplants Corporation

XENOXeno Transplants Corporation$0.00+0.00%

TNGNQTengion, Inc.

TNGNQTengion, Inc.$0.00+0.00%

BTTXBetter Therapeutics, Inc.

BTTXBetter Therapeutics, Inc.$0.00+0.00%

AMPEAmpio Pharmaceuticals, Inc.

AMPEAmpio Pharmaceuticals, Inc.$0.01+0.00%

TLOGTetraLogic Pharmaceuticals Corporation

TLOGTetraLogic Pharmaceuticals Corporation$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About IVBT

What is the current price of Innovation1 Biotech?

Innovation1 Biotech is trading at $0.00 per share.

What is the 52-week range for Innovation1 Biotech?

Over the past 52 weeks, Innovation1 Biotech has traded between $0.00 and $0.01.

How much debt does Innovation1 Biotech have?

As of the most recent reporting period, Innovation1 Biotech reported total debt of $228,999.

How much cash does Innovation1 Biotech have on hand?

Innovation1 Biotech reported $49,849 in cash and cash equivalents in its most recent financial results.

What is Innovation1 Biotech’s dividend yield?

Innovation1 Biotech does not currently have a dividend yield.

Innovation1 Biotech

Innovation1 Biotech Financials at a Glance

IVBT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Innovation1 Biotech

IVBT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Innovation1 Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IVBT

What is the current price of Innovation1 Biotech?

What is the 52-week range for Innovation1 Biotech?

How much debt does Innovation1 Biotech have?

How much cash does Innovation1 Biotech have on hand?

What is Innovation1 Biotech’s dividend yield?

Premium Investing Services